Publication:
Abciximab-Induced Thrombocytopenia: Correct Management

Simple item page
dc.authorscopusid6504527476
dc.authorscopusid57967944700
dc.authorscopusid57968249700
dc.authorscopusid56689513900
dc.contributor.authorKelkitli, E.
dc.contributor.authorOdabaşi Giden, A.
dc.contributor.authorDenız Kürekçi, D.
dc.contributor.authorTurgut, M.
dc.date.accessioned2025-12-11T00:30:15Z
dc.date.issued2022
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Kelkitli] Engin, Department of Hematology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Odabaşi Giden] Aslı, Department of Hematology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Denız Kürekçi] Derya, Department of Hematology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Turgut] Mehmet, Department of Hematology, Ondokuz Mayis University, Medical School, Samsun, Turkeyen_US
dc.description.abstractThrombocytopenia is a possible side effect of routinely administered medical agents. Abciximab is one of the three potent intravenous glycoprotein IIb/IIIa receptor inhibitors (along with eptifibatide and tirofiban) that have shown significant positive outcomes when used in patients with intracoronary thrombus. The use of abciximab was associated with the risk of thrombocytopenia. This case reported the development of thrombocytopenia and treatment management after using abciximab. © 2022 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.identifier.doi10.52142/omujecm.39.2.58
dc.identifier.endpage583en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85142025359
dc.identifier.scopusqualityQ4
dc.identifier.startpage581en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.39.2.58
dc.identifier.urihttps://hdl.handle.net/20.500.12712/36879
dc.identifier.volume39en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Universityen_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAbciximaben_US
dc.subjectGlycoprotein IIb/IIIa Receptor Inhibitorsen_US
dc.subjectSide Effecten_US
dc.subjectThrombocytopeniaen_US
dc.titleAbciximab-Induced Thrombocytopenia: Correct Managementen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files

Collections

Scopus İndeksli Yayınlar Koleksiyonu